Renal mass sampling: An enlightened perspective

International Journal of Urology

Volumn 18, Issue 1, 2011, Pages 5-19

  Samplaski, Mary K ^a   Zhou, Ming ^b   Lane, Brian R ^d   Herts, Brian ^c   Campbell, Steve C ^a  

^a Glickman Urological   (United States)

^b Pathology and Laboratory Medicine Institute   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d SPECTRUM HEALTH   (United States)

Author keywords

Angiomyolipoma; Fine needle aspiration; Oncocytoma; Renal cell carcinoma; Renal mass biopsy

Indexed keywords

BIOLOGICAL MARKER;

ABLATION THERAPY; ANGIOMYOLIPOMA; ASPIRATION BIOPSY; BLEEDING; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GRADING; CLEAR CELL CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ECHOGRAPHY; EXCISION; FALSE ANEURYSM; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GENETIC ANALYSIS; HEMATOMA; HUMAN; IMMUNOPHENOTYPING; KIDNEY BIOPSY; KIDNEY CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOCYTOMA; PAPILLARY CARCINOMA; PNEUMOTHORAX; PRIORITY JOURNAL; REPEAT PROCEDURE; REVIEW; SENSITIVITY AND SPECIFICITY; TUMOR SEEDING;

BIOPSY; FALSE NEGATIVE REACTIONS; HUMANS; KIDNEY; KIDNEY NEOPLASMS;

EID: 78650665246     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2010.02641.x     Document Type: Review

References (117)

1. Cancer IAfRo. GLOBOCAN. 2002.
2. Tada S, Yamagishi J, Kobayashi H, Hata Y, Kobari T. The incidence of simple renal cyst by computed tomography. Clin. Radiol. 1983; 34: 437-9.
3. Hara AK, Johnson CD, MacCarty RL, Welch TJ. Incidental extracolonic findings at CT colonography. Radiology 2000; 215: 353-7.
4. Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States. JAMA 1999; 281: 1628-31.
5. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J. Clin. 2001; 51: 15-36.
6. Ozen H, Colowick A, Freiha FS. Incidentally discovered solid renal masses: what are they? Br. J. Urol. 1993; 72: 274-6.
7. Patard JJ, Tazi H, Bensalah K et al. The changing evolution of renal tumours: a single center experience over a two-decade period. Eur. Urol. 2004; 45: 490-3; discussion 493-4.
8. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J. Natl. Cancer Inst. 2006; 98: 1331-4.
9. Nguyen MM, Gill IS, Ellison LM. The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program. J. Urol. 2006; 176: 2397-400; discussion 2400.
10. Silverman SG, Israel GM, Herts BR, Richie JP. Management of the incidental renal mass. Radiology 2008; 249: 16-31.
11. Remzi M, Ozsoy M, Klingler HC et al. Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter. J. Urol. 2006; 176: 896-9.
12. Kim JK, Park SY, Shon JH, Cho KS. Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT. Radiology 2004; 230: 677-84.
13. Kim JK, Kim SH, Jang YJ et al. Renal angiomyolipoma with minimal fat: differentiation from other neoplasms at double-echo chemical shift FLASH MR imaging. Radiology 2006; 239: 174-80.
14. Remzi M, Katzenbeisser D, Waldert M et al. Renal tumour size measured radiologically before surgery is an unreliable variable for predicting histopathological features: benign tumours are not necessarily small. BJU Int. 2007; 99: 1002-6.
15. Shannon BA, Cohen RJ, de Bruto H, Davies RJ. The value of preoperative needle core biopsy for diagnosing benign lesions among small, incidentally detected renal masses. J. Urol. 2008; 180: 1257-61; discussion 1261.
16. Sant GR, Heaney JA, Ucci AA Jr, Sarno RC, Meares EM Jr. Computed tomographic findings in renal angiomyolipoma: an histologic correlation. Urology 1984; 24: 293-6.
17. Chao DH, Zisman A, Pantuck AJ, Freedland SJ, Said JW, Belldegrun AS. Changing concepts in the management of renal oncocytoma. Urology 2002; 59: 635-42.
18. Fielding JR, Visweswaran A, Silverman SG, Granter SR, Renshaw AA. CT and ultrasound features of metanephric adenoma in adults with pathologic correlation. J. Comput. Assist. Tomogr. 1999; 23: 441-4.
19. Xiong YH, Zhang ZL, Li YH et al. Benign pathological findings in 303 Chinese patients undergoing surgery for presumed localized renal cell carcinoma. Int. J. Urol. 2010; 17: 517-21.
20. Fujii Y, Komai Y, Saito K et al. Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese dual-center experience with 176 consecutive patients. Urology 2008; 72: 598-602.
21. Lee SH, Park SU, Rha KH et al. Trends in the incidence of benign pathological lesions at partial nephrectomy for presumed renal cell carcinoma in renal masses on preoperative computed tomography imaging: a single institute experience with 290 consecutive patients. Int. J. Urol. 2010; 17: 512-16.
22. Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet 2009; 373: 1119-32.
23. Kattan MW, Reuter V, Motzer RJ, Katz J, Russo P. A postoperative prognostic nomogram for renal cell carcinoma. J. Urol. 2001; 166: 63-7.
24. Zambrano NR, Lubensky IA, Merino MJ, Linehan WM, Walther MM. Histopathology and molecular genetics of renal tumors toward unification of a classification system. J. Urol. 1999; 162: 1246-58.
25. Jeldres C, Sun M, Liberman D et al. Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model? J. Urol. 2009; 182: 2585-9.
26. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J. Urol. 2003; 170: 2217-20.
27. Lane BR, Samplaski MK, Herts BR, Zhou M, Novick AC, Campbell SC. Renal mass biopsy - a renaissance? J. Urol. 2008; 179: 20-7.
28. Lane BR, Babineau D, Kattan MW et al. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy. J. Urol. 2007; 178: 429-34.
29. Abouassaly R, Lane BR, Novick AC. Active surveillance of renal masses in elderly patients. J. Urol. 2008; 180: 505-8; discussion 508-9.
30. Neuzillet Y, Lechevallier E, Andre M, Daniel L, Nahon O, Coulange C. Follow-up of renal oncocytoma diagnosed by percutaneous tumor biopsy. Urology 2005; 66: 1181-5.
31. Vasudevan A, Davies RJ, Shannon B, Cohen R. Incidental renal tumours: the frequency of benign lesions and the role of preoperative core biopsy. BJU Int. 2006; 97: 946-9.
32. Beland MD, Mayo-Smith WW, Dupuy DE, Cronan JJ, DeLellis RA. Diagnostic yield of 58 consecutive imaging-guided biopsies of solid renal masses: should we biopsy all that are indeterminate? AJR Am. J. Roentgenol. 2007; 188: 792-7.
33. Lebret T, Poulain JE, Molinie V et al. Percutaneous core biopsy for renal masses: indications, accuracy and results. J. Urol. 2007; 178: 1184-8; discussion 1188.
34. Maturen KE, Nghiem HV, Caoili EM, Higgins EG, Wolf JS Jr, Wood DP Jr. Renal mass core biopsy: accuracy and impact on clinical management. AJR Am. J. Roentgenol. 2007; 188: 563-70.
35. Reichelt O, Gajda M, Chyhrai A, Wunderlich H, Junker K, Schubert J. Ultrasound-guided biopsy of homogenous solid renal masses. Eur. Urol. 2007; 52: 1421-6.
36. Somani BK, Nabi G, Thorpe P, N'Dow J, Swami S, McClinton S. Image-guided biopsy-diagnosed renal cell carcinoma: critical appraisal of technique and long-term follow-up. Eur. Urol. 2007; 51: 1289-95; discussion 1296-7.
37. Schmidbauer J, Remzi M, Memarsadeghi M et al. Diagnostic accuracy of computed tomography-guided percutaneous biopsy of renal masses. Eur. Urol. 2008; 53: 1003-11.
38. Volpe A, Mattar K, Finelli A et al. Contemporary results of percutaneous biopsy of 100 small renal masses: a single center experience. J. Urol. 2008; 180: 2333-7.
39. Masoom S, Venkataraman G, Jensen J, Flanigan RC, Wojcik EM. Renal FNA-based typing of renal masses remains a useful adjunctive modality: evaluation of 31 renal masses with correlative histology. Cytopathology 2009; 20: 50-5.
40. Wang R, Wolf JS Jr, Wood DP Jr, Higgins EJ, Hafez KS. Accuracy of percutaneous core biopsy in management of small renal masses. Urology 2009; 73: 586-90; discussion 590-1.
41. Johnson PT, Nazarian LN, Feld RI et al. Sonographically guided renal mass biopsy: indications and efficacy. J. Ultrasound Med. 2001; 20: 749-53; quiz 55.
42. Tang S, Li JH, Lui SL, Chan TM, Cheng IK, Lai KN. Free-hand, ultrasound-guided percutaneous renal biopsy: experience from a single operator. Eur. J. Radiol. 2002; 41: 65-9.
43. Volpe A, Kachura JR, Geddie WR et al. Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. J. Urol. 2007; 178: 379-86.
44. Lu DS, Silverman SG, Raman SS. MR-guided therapy. Applications in the abdomen. Magn. Reson. Imaging Clin. N. Am. 1999; 7: 337-48.
45. Haber GP, Colombo JR, Remer E et al. Synchronized real-time ultrasonography and three-dimensional computed tomography scan navigation during percutaneous renal cryoablation in a porcine model. J. Endourol. 2010; 24: 333-7.
46. Volpe A, Jewett MA. Current role, techniques and outcomes of percutaneous biopsy of renal tumors. Expert Rev. Anticancer Ther. 2009; 9: 773-83.
47. Terrone C, Volpe A. The role of pathology for clinical decision-making in renal cell carcinoma is increasing. Eur. Urol. 2007; 51: 1166-8; discussion 1168-70.
48. Appelbaum AH, Kamba TT, Cohen AS, Qaisi WG, Amirkhan RH. Effectiveness and safety of image-directed biopsies: coaxial technique versus conventional fine-needle aspiration. South. Med. J. 2002; 95: 212-17.
49. Barocas DA, Mathew S, DelPizzo JJ et al. Renal cell carcinoma sub-typing by histopathology and fluorescence in situ hybridization on a needle-biopsy specimen. BJU Int. 2007; 99: 290-5.
50. Truong LD, Todd TD, Dhurandhar B, Ramzy I. Fine-needle aspiration of renal masses in adults: analysis of results and diagnostic problems in 108 cases. Diagn. Cytopathol. 1999; 20: 339-49.
51. Schieven LW, Smedts F, Hopman AH, van der Wijk J, Nijman RJ, de Jong IJ. Fine needle aspiration using improved agar microbiopsy is highly concordant with renal mass final diagnosis and subclassification. J. Urol. 2009; 182: 2590-3.
52. Garcia-Solano J, Acosta-Ortega J, Perez-Guillermo M, Benedicto-Orovitg JM, Jimenez-Penick FJ. Solid renal masses in adults: image-guided fine-needle aspiration cytology and imaging techniques -"two heads better than one?" Diagn. Cytopathol. 2008; 36: 8-12.
53. Kummerlin IP, ten Kate FJ, Wijkstra H, de la Rosette JJ, Laguna MP. Changes in the stage and surgical management of renal tumours during 1995-2005: an analysis of the Dutch national histopathology registry. BJU Int. 2008; 102: 946-51.
54. Wunderlich H, Hindermann W, Al Mustafa AM, Reichelt O, Junker K, Schubert J. The accuracy of 250 fine needle biopsies of renal tumors. J. Urol. 2005; 174: 44-6.
55. Neuzillet Y, Lechevallier E, Andre M, Daniel L, Coulange C. Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses. J. Urol. 2004; 171: 1802-5.
56. Rybicki FJ, Shu KM, Cibas ES, Fielding JR, vanSonnenberg E, Silverman SG. Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses. AJR Am. J. Roentgenol. 2003; 180: 1281-7.
57. Lechevallier E, Andre M, Barriol D et al. Fine-needle percutaneous biopsy of renal masses with helical CT guidance. Radiology 2000; 216: 506-10.
58. Caoili EM, Bude RO, Higgins EJ, Hoff DL, Nghiem HV. Evaluation of sonographically guided percutaneous core biopsy of renal masses. AJR Am. J. Roentgenol. 2002; 179: 373-8.
59. Breda A, Treat EG, Haft-Candell L et al. Comparison of accuracy of 14-, 18- and 20-G needles in ex-vivo renal mass biopsy: a prospective, blinded study. BJU Int. 2010; 105: 940-5.
60. Wood BJ, Khan MA, McGovern F, Harisinghani M, Hahn PF, Mueller PR. Imaging guided biopsy of renal masses: indications, accuracy and impact on clinical management. J. Urol. 1999; 161: 1470-4.
61. Kummerlin I, ten Kate F, Smedts F et al. Diagnostic problems in the subtyping of renal tumors encountered by five pathologists. Pathol. Res. Pract. 2009; 205: 27-34.
62. Kummerlin IP, Smedts F, ten Kate FJ et al. Cytological punctures in the diagnosis of renal tumours: a study on accuracy and reproducibility. Eur. Urol. 2009; 55: 187-95.
63. Vasudevan A, Davies RJ, Shannon BA, Cohen RJ. Incidental renal tumours: the frequency of benign lesions and the role of preoperative core biopsy. BJU Int. 2006; 97: 946-9.
64. Herts BR, Baker ME. The current role of percutaneous biopsy in the evaluation of renal masses. Semin. Urol. Oncol. 1995; 13: 254-61.
65. Vasselli JR, Shih JH, Iyengar SR et al. Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor. Proc. Natl. Acad. Sci. USA 2003; 100: 6958-63.
66. Nenning H, Rassler J, Minh DH. Heterogeneity of DNA distribution pattern in renal tumours. Anal. Cell. Pathol. 1997; 14: 9-17.
67. Kummerlin I, ten Kate F, Smedts F et al. Core biopsies of renal tumors: a study on diagnostic accuracy, interobserver, and intraobserver variability. Eur. Urol. 2008; 53: 1219-25.
68. Liu J, Fanning CV. Can renal oncocytomas be distinguished from renal cell carcinoma on fine-needle aspiration specimens? A study of conventional smears in conjunction with ancillary studies. Cancer 2001; 93: 390-7.
69. Skinnider BF, Amin MB. An immunohistochemical approach to the differential diagnosis of renal tumors. Semin. Diagn. Pathol. 2005; 22: 51-68.
70. Johnson NB, Johnson MM, Selig MK, Nielsen GP. Use of electron microscopy in core biopsy diagnosis of oncocytic renal tumors. Ultrastruct. Pathol. 2010; 34: 189-94.
71. Cajulis RS, Katz RL, Dekmezian R, el-Naggar A, Ro JY. Fine needle aspiration biopsy of renal cell carcinoma. Cytologic parameters and their concordance with histology and flow cytometric data. Acta Cytol. 1993; 37: 367-72.
72. Al Nazer M, Mourad WA. Successful grading of renal-cell carcinoma in fine-needle aspirates. Diagn. Cytopathol. 2000; 22: 223-6.
73. Nagy A, Buzogany I, Kovacs G. Microsatellite allelotyping differentiates chromophobe renal cell carcinomas from renal oncocytomas and identifies new genetic changes. Histopathology 2004; 44: 542-6.
74. Escudier B, Eisen T, Stadler WM et al. Sorafenib in advanced clear-cell renal-cell carcinoma. N. Engl. J. Med. 2007; 356: 125-34.
75. Motzer RJ, Hutson TE, Tomczak P et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N. Engl. J. Med. 2007; 356: 115-24.
76. Abe M, Saitoh M. Selective renal tumour biopsy under ultrasonic guidance. Br. J. Urol. 1992; 70: 7-11.
77. Abou Youssif T, Kassouf W, Steinberg J, Aprikian AG, Laplante MP, Tanguay S. Active surveillance for selected patients with renal masses: updated results with long-term follow-up. Cancer 2007; 110: 1010-14.
78. Rendon RA, Stanietzky N, Panzarella T et al. The natural history of small renal masses. J. Urol. 2000; 164: 1143-7.
79. Cardella JF, Bakal CW, Bertino RE et al. Quality improvement guidelines for image-guided percutaneous biopsy in adults. J. Vasc. Interv. Radiol. 2003; 14: S227-S230.
80. Welch TJ, Sheedy PF II, Johnson CD, Johnson CM, Stephens DH. CT-guided biopsy: prospective analysis of 1, 000 procedures. Radiology 1989; 171: 493-6.
81. Sahni VA, Silverman SG. Biopsy of renal masses: when and why. Cancer Imaging 2009; 9: 44-55.
82. Silverman SG, Gan YU, Mortele KJ, Tuncali K, Cibas ES. Renal masses in the adult patient: the role of percutaneous biopsy. Radiology 2006; 240: 6-22.
83. Lee CT, Katz J, Shi W, Thaler HT, Reuter VE, Russo P. Surgical management of renal tumors 4 cm or less in a contemporary cohort. J. Urol. 2000; 163: 730-6.
84. Glassman D, Chawla SN, Waldman I et al. Correlation of pathology with tumor size of renal masses. Can. J. Urol. 2007; 14: 3616-20.
85. Schachter LR, Cookson MS, Chang SS et al. Second prize: frequency of benign renal cortical tumors and histologic subtypes based on size in a contemporary series: what to tell our patients. J. Endourol. 2007; 21: 819-23.
86. Azizi B, Whelan T, Morse M. Renal tumors and the risk of malignancy based on size. Can. J. Urol. 2009; 16: 4921-3.
87. Schlomer B, Figenshau RS, Yan Y, Venkatesh R, Bhayani SB. Pathological features of renal neoplasms classified by size and symptomatology. J. Urol. 2006; 176: 1317-20; discussion 1320.
88. Thompson RH, Kurta JM, Kaag M et al. Tumor size is associated with malignant potential in renal cell carcinoma cases. J. Urol. 2009; 181: 2033-6.
89. Volpe A, Panzarella T, Rendon RA, Haider MA, Kondylis FI, Jewett MA. The natural history of incidentally detected small renal masses. Cancer 2004; 100: 738-45.
90. Kassouf W, Aprikian AG, Laplante M, Tanguay S. Natural history of renal masses followed expectantly. J. Urol. 2004; 171: 111-13; discussion 113.
91. Wehle MJ, Thiel DD, Petrou SP, Young PR, Frank I, Karsteadt N. Conservative management of incidental contrast-enhancing renal masses as safe alternative to invasive therapy. Urology 2004; 64: 49-52.
92. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J. Urol. 2006; 175: 425-31.
93. Huang WC, Levey AS, Serio AM et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol. 2006; 7: 735-40.
94. Gill IS, Aron M, Gervais DA, Jewett MA. Clinical practice. Small renal mass. N. Engl. J. Med. 2010; 362: 624-34.
95. Tuncali K, vanSonnenberg E, Shankar S, Mortele KJ, Cibas ES, Silverman SG. Evaluation of patients referred for percutaneous ablation of renal tumors: importance of a preprocedural diagnosis. AJR Am. J. Roentgenol. 2004; 183: 575-82.
96. Javadi S, Matin SF, Tamboli P, Ahrar K. Unexpected atypical findings on CT after radiofrequency ablation for small renal-cell carcinoma and the role of percutaneous biopsy. J. Vasc. Interv. Radiol. 2007; 18: 1186-91.
97. Lang EK. Renal cyst puncture studies. Urol. Clin. North Am. 1987; 14: 91-102.
98. Curry NS, Cochran ST, Bissada NK. Cystic renal masses: accurate Bosniak classification requires adequate renal CT. AJR Am. J. Roentgenol. 2000; 175: 339-42.
99. Richter F, Kasabian NG, Irwin RJ Jr, Watson RA, Lang EK. Accuracy of diagnosis by guided biopsy of renal mass lesions classified indeterminate by imaging studies. Urology 2000; 55: 348-52.
100. Lang EK, Macchia RJ, Gayle B et al. CT-guided biopsy of indeterminate renal cystic masses (Bosniak 3 and 2F): accuracy and impact on clinical management. Eur. Radiol. 2002; 12: 2518-24.
101. Li G, Feng G, Cuilleron M et al. CA9 level in renal cyst fluid: a possible molecular diagnosis of malignant tumours. Histopathology 2009; 54: 880-4.
102. Pospihalj B, Zamparese R, Mazzucchelli R, Morichetti D. Kidney cancer: not a single disease. Anal. Quant. Cytol. Histol. 2007; 29: 377-9.
103. Rini BI. Metastatic renal cell carcinoma: many treatment options, one patient. J. Clin. Oncol. 2009; 27: 3225-34.
104. Thomas AA, Rini BI, Campbell SC. Integration of surgery and systemic therapy in the management of metastatic renal cancer. Curr. Urol. Rep. 2009; 10: 35-41.
105. Niceforo J, Coughlin BF. Diagnosis of renal cell carcinoma: value of fine-needle aspiration cytology in patients with metastases or contraindications to nephrectomy. AJR Am. J. Roentgenol. 1993; 161: 1303-5.
106. Barocas DA, Rohan SM, Kao J et al. Diagnosis of renal tumors on needle biopsy specimens by histological and molecular analysis. J. Urol. 2006; 176: 1957-62.
107. Zhou M, Roma A, Magi-Galluzzi C. The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms. Clin. Lab. Med. 2005; 25: 247-57.
108. Jinzaki M, Tanimoto A, Narimatsu Y et al. Angiomyolipoma: imaging findings in lesions with minimal fat. Radiology 1997; 205: 497-502.
109. Shinmoto H, Yuasa Y, Tanimoto A et al. Small renal cell carcinoma: MRI with pathologic correlation. J. Magn. Reson. Imaging 1998; 8: 690-4.
110. Aydin H, Magi-Galluzzi C, Lane BR et al. Renal angiomyolipoma: clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association. Am. J. Surg. Pathol. 2009; 33: 289-97.
111. Nelson CP, Sanda MG. Contemporary diagnosis and management of renal angiomyolipoma. J. Urol. 2002; 168: 1315-25.
112. Sturtz CL, Dabbs DJ. Angiomyolipomas: the nature and expression of the HMB45 antigen. Mod. Pathol. 1994; 7: 842-5.
113. Roh MH, Dal Cin P, Silverman SG, Cibas ES. The application of cytogenetics and fluorescence in situ hybridization to fine-needle aspiration in the diagnosis and subclassification of renal neoplasms. Cancer Cytopathol. 2010; 118: 137-45.
114. Li G, Cuilleron M, Cottier M et al. The use of MN/CA9 gene expression in identifying malignant solid renal tumors. Eur. Urol. 2006; 49: 401-5.
115. Takahashi M, Rhodes DR, Furge KA et al. Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc. Natl. Acad. Sci. USA 2001; 98: 9754-9.
116. Tan MH, Rogers CG, Cooper JT et al. Gene expression profiling of renal cell carcinoma. Clin. Cancer Res. 2004; 10: 6315S-6321S.
117. Yang XJ, Sugimura J, Schafernak KT et al. Classification of renal neoplasms based on molecular signatures. J. Urol. 2006; 175: 2302-6.